Join
Live feed
·
PRReleasevia Quantisnow
Boston Scientific Corporation logo

HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

ByQuantisnow·Wall Street's wire, on your screen.
BSX· Boston Scientific Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BSX (Boston Scientific Corporation) and more on Quantisnow.